← Back to Search

Diagnostic Test

Postpartum Diabetes Screening for Gestational Diabetes

N/A
Recruiting
Led By Christine Field, MD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 year postpartum
Awards & highlights

Study Summary

This trial will compare postpartum diabetes screening done before and after delivery to see which is better at detecting diabetes.

Who is the study for?
This trial is for English or Spanish-speaking individuals who were diagnosed with gestational diabetes during pregnancy, are at least 18 years old, and can give informed consent. They must be receiving care at OSU and be immediately postpartum during their delivery hospital stay. Those with a history of gastric bypass or unable to tolerate an OGTT cannot participate.Check my eligibility
What is being tested?
The DIP trial is testing if doing a glucose tolerance test (OGTT) right after giving birth in the hospital helps more new moms get screened for diabetes compared to waiting for the standard 4-12 weeks after delivery. Participants will either receive this immediate test or follow the usual care plan.See study design
What are the potential side effects?
Since this study involves standard glucose tolerance tests, side effects may include discomfort from fasting before the test, feeling lightheaded or nauseous during or after drinking the glucose solution, and potential bruising from blood draws.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1 year postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 1 year postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of postpartum diabetes mellitus screening
Secondary outcome measures
Diabetes Treatment Satisfaction Questionnaire
Prediabetes or type 2 diabetes
Rates of primary care provider (PCP) visits within 1 year of delivery
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard of careExperimental Treatment1 Intervention
Standard of care is 4-12 week outpatient postpartum OGTT
Group II: Immediate inpatient postpartum OGTTActive Control1 Intervention
The intervention includes immediate inpatient postpartum 2-hour oral glucose tolerance test (OGTT) prior to delivery discharge

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
830 Previous Clinical Trials
505,516 Total Patients Enrolled
Christine Field, MDPrincipal InvestigatorOhio State University
Kartik K Venkatesh, MD, PhDPrincipal InvestigatorOhio State University
1 Previous Clinical Trials
124 Total Patients Enrolled

Media Library

Immediate inpatient postpartum OGTT (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT05909046 — N/A
Gestational Diabetes Research Study Groups: Immediate inpatient postpartum OGTT, Standard of care
Gestational Diabetes Clinical Trial 2023: Immediate inpatient postpartum OGTT Highlights & Side Effects. Trial Name: NCT05909046 — N/A
Immediate inpatient postpartum OGTT (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05909046 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being enrolled at this time for the study?

"Records hosted on clinicaltrials.gov inform us that this medical study is not actively seeking participants, though it was first posted back in July of 2023 and last updated just a few months ago in June. Nevertheless, there are presently 1,246 other studies currently recruiting for candidates."

Answered by AI
~32 spots leftby Sep 2024